Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ring-fused compound of tetrahydropyrrole and piperazinedione as well as preparation and pharmaceutical application of ring-fused compound of tetrahydropyrrole and piperazinedione

A technology of diketopiperazine and tetrahydropyrrole is applied in the field of medicinal chemistry, and can solve the problems of clinical treatment of dengue fever diseases without dengue virus.

Active Publication Date: 2022-07-29
CHANGZHOU VOCATIONAL INST OF ENG
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Under the influence of many factors such as global environmental deterioration and warming, the dengue fever epidemic has been expanding in recent years. However, there is currently only one dengue vaccine in a limited area, and there is no effective anti-dengue virus drug available for clinical treatment of dengue fever. Now clinical treatment is mainly gradual supportive therapy, in which maintaining fluid balance is the main means

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ring-fused compound of tetrahydropyrrole and piperazinedione as well as preparation and pharmaceutical application of ring-fused compound of tetrahydropyrrole and piperazinedione
  • Ring-fused compound of tetrahydropyrrole and piperazinedione as well as preparation and pharmaceutical application of ring-fused compound of tetrahydropyrrole and piperazinedione
  • Ring-fused compound of tetrahydropyrrole and piperazinedione as well as preparation and pharmaceutical application of ring-fused compound of tetrahydropyrrole and piperazinedione

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The present invention provides a preparation method of the above compound, comprising the following steps:

[0033]

[0034] The following specific compounds were prepared as described above:

[0035]

[0036]

[0037]

[0038]

Embodiment 2

[0040] Protease activity assay procedures refer to published papers. (Zhou G C, Weng Z, Shao X, et al. Discovery and SAR studies of methionine-proline anilides as dengue virusNS2B-NS3 protease inhibitors[J].Bioorganic&medicinal chemistry letters,2013,23(24):6549-6554.) Partial compounds Activity data for NS2b-NS3 are presented below.

[0041]

[0042]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention is applicable to the field of medicinal chemistry, and provides a fused ring compound of tetrahydropyrrole and piperazinedione as well as preparation and pharmaceutical application of the fused ring compound, and the compound is a compound shown in the formula or other pharmaceutically acceptable salts. The compound disclosed by the invention has the functions of inhibiting infection and replication of the dengue virus, so that the compound disclosed by the invention can be used as a medicine for preventing and treating diseases caused by the dengue virus.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a cyclic compound of tetrahydropyrrole and diketopiperazine and its preparation and pharmaceutical use. Background technique [0002] Dengue fever (DF) is an acute infectious disease caused by dengue virus (DENV), which is transmitted through the bite of female mosquitoes. Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). About 390 million people are infected with DENV each year, affecting 128 countries. [0003] Under the influence of many factors such as global environmental deterioration and warming, the dengue fever epidemic has tended to expand in recent years, but currently there is only one dengue vaccine for limited areas, and no effective anti-dengue virus drugs can be used for clinical treatment of dengue fever disease. The current clinical treatment is mainly progressive supportive therapy, in which the maintenance of body fluid balance is the main me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D487/04A61K31/4985A61P31/14
CPCC07D487/04A61P31/14C07B2200/07Y02A50/30
Inventor 翁智兵周海平田苗陈绘如
Owner CHANGZHOU VOCATIONAL INST OF ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com